Monday, May 20, 2013

• Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial Design for Bavituximab in Second-Line Non-Small Cell Lung CancerMarketwired( (Mon, May 20)

Thursday, May 16, 2013

• Peregrine Pharmaceuticals' Immunotherapy Bavituximab to Be Highlighted in Three Clinical Data Presentations at 2013 ASCO Annual MeetingMarketwired( (Thu, May 16)

Monday, April 29, 2013

• Peregrine Announces Completion of Patient Enrollment in Breast Cancer Clinical Trial for BavituximabMarketwired( (Mon, Apr 29)

Wednesday, April 10, 2013

• Data Presented at AACR Annual Meeting Support Targeted Immune Reactivation Mechanism and Potential of Peregrine's Bavituximab in Solid Tumor TherapyMarketwired( (Wed, Apr 10)

Tuesday, April 9, 2013

• Faruqi & Faruqi, LLP is Investigating Peregrine Pharmaceuticals Inc. on Behalf of its Shareholders - PPHMPR Newswire( (Tue, Apr 9)

Monday, April 1, 2013

• Peregrine Announces Three Abstracts Accepted for Presentation at AACR 2013 Annual MeetingMarketwired( (Mon, Apr 1)

Tuesday, March 12, 2013

• Peregrine Pharmaceuticals Reports Third Quarter Fiscal Year 2013 Financial Results and Recent DevelopmentsMarketwired( (Tue, Mar 12)

Monday, March 11, 2013

• FDA's New "Breakthrough" Designation Allows New Drugs to Gain Approval After Just 1 Round of TestingMarketwired( (Mon, Mar 11)

Tuesday, March 5, 2013

• Peregrine to Report Third Quarter Fiscal Year 2013 Financial Results After Market Close on March 12, 2013Marketwired( (Tue, Mar 5)

Tuesday, February 26, 2013

• Peregrine Announces Participation at Upcoming Investor ConferencesMarketwired( (Tue, Feb 26)
• Avid Bioservices to Highlight Recent Successes in Reducing Manufacturing Costs and Novel Ways of Controlling Critical Process Parameters That Lead to Consistent Product Quality at IBC'S Biopharmaceutical Development and Production ConferencMarketwired( (Tue, Feb 26)

Tuesday, February 19, 2013

• Peregrine Pharmaceuticals Updates Top-Line Data From Phase II Clinical Trial of Bavituximab in Second-Line Non-Small Cell Lung CancerMarketwired( (Tue, Feb 19)

Thursday, February 14, 2013

• U.S. Food and Drug Administration Approved 30% More Drugs in 2012Marketwired( (Thu, Feb 14)